Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 207,705 | 211,572 | 192,103 | 165,453 | 149,824 |
| Cost of Goods | 23,391 | 23,007 | 18,965 | 16,827 | 15,763 |
| Gross Profit | 184,314 | 188,565 | 173,138 | 148,626 | 134,061 |
| Operating Expenses | 193,037 | 192,509 | 234,334 | 137,312 | 145,080 |
| Operating Income | -8,332 | -3,937 | -60,231 | 12,141 | -10,256 |
| Other Income | 2,382 | 2,023 | 2,277 | 4,528 | 4,425 |
| Pre-tax Income | -5,950 | -1,914 | -57,954 | 16,669 | -5,831 |
| Income Tax | -3,657 | 2,191 | -12,837 | -5,830 | 5,996 |
| Net Income Continuous | -2,293 | -4,105 | -45,117 | 22,499 | -11,827 |
| Net Income | $-2,293 | $-4,105 | $-45,117 | $22,499 | $-11,827 |
| EPS Basic Total Ops | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 |
| EPS Basic Continuous Ops | -0.04 | -0.08 | -0.80 | 0.40 | -0.21 |
| EPS Diluted Total Ops | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 |
| EPS Diluted Continuous Ops | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 |
| EPS Diluted Before Non-Recurring Items | 0.45 | 0.75 | 0.46 | 0.78 | 0.28 |
| EBITDA(a) | $17,608 | $21,577 | $-36,346 | $33,467 | $9,053 |